List of Kissei Pharmaceutical patents | 7 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10016433 Salt of fused heterocyclic derivative and crystal thereof	Patent 10016433 was granted and assigned to Kissei Pharmaceutical on July, 2018 by the United States Patent and Trademark Office.	Kissei Pharmaceutical	Kissei Pharmaceutical	United States Patent and Trademark Office	10016433	July 10, 2018
‌ US Patent 9708266 Cyclohexyl pyridine derivative	Patent 9708266 was granted and assigned to Kissei Pharmaceutical on July, 2017 by the United States Patent and Trademark Office.	Kissei Pharmaceutical	Kissei Pharmaceutical	United States Patent and Trademark Office	9708266	July 18, 2017
‌ US Patent 9988350 Aniline derivative, pharmaceutical composition containing same, and use thereof	Patent 9988350 was granted and assigned to Kissei Pharmaceutical on June, 2018 by the United States Patent and Trademark Office.		Kissei Pharmaceutical	United States Patent and Trademark Office	9988350	June 5, 2018
‌ US Patent 9718771 Aniline derivative, pharmaceutical composition containing same, and use thereof	Patent 9718771 was granted and assigned to Kissei Pharmaceutical on August, 2017 by the United States Patent and Trademark Office.		Kissei Pharmaceutical	United States Patent and Trademark Office	9718771	August 1, 2017
‌ US Patent 10995084 Pyrrolidine derivative	Patent 10995084 was granted and assigned to Kissei Pharmaceutical on May, 2021 by the United States Patent and Trademark Office.	Kissei Pharmaceutical	Kissei Pharmaceutical	United States Patent and Trademark Office	10995084	May 4, 2021
‌ US Patent 10011568 Cyclohexyl pyridine derivative	Patent 10011568 was granted and assigned to Kissei Pharmaceutical on July, 2018 by the United States Patent and Trademark Office.	Kissei Pharmaceutical	Kissei Pharmaceutical	United States Patent and Trademark Office	10011568	July 3, 2018
‌ US Patent 11759464 Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood loss	Patent 11759464 was granted and assigned to Kissei Pharmaceutical on September, 2023 by the United States Patent and Trademark Office.	ObsEva	Kissei Pharmaceutical	United States Patent and Trademark Office	11759464	September 19, 2023